| Financial Year |
March 31 2023 |
| Monetary Funds |
419,234,526.90 |
| Held-for-trading Financial Assets |
10,007,888.89 |
| Notes Receivable |
277,929,119.23 |
| Accounts Receivable |
1,514,093,458.35 |
| Advances to Suppliers |
55,232,250.31 |
| Other Receivables |
19,130,991.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
290,936.68 |
| Dividend Receivable |
-- |
| Inventories |
950,743,969.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
616,245.43 |
| Other Current Assets |
74,283,126.16 |
| Total Current Assets |
3,377,436,066.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,509,158.83 |
| Long-term Equity Investment |
118,769,557.29 |
| Investment Properties |
1,347,581.70 |
| Fixed Assetes |
1,726,307,920.68 |
| Under-construction Projects |
419,006,019.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
201,326,749.09 |
| R&D expenses |
-- |
| Goodwill |
1,829,490,322.72 |
| Long-Term Deferred and Prepaid Expenses |
9,635,142.80 |
| Deferred Income Tax Assets |
44,595,786.65 |
| Other Non-Current Assets |
147,740,837.12 |
| Sub-Total of Non-Current Assets |
4,596,374,870.47 |
| Total Assets |
7,973,810,937.38 |
| Short-Term Loans |
40,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
70,225,484.87 |
| Accounts Payable |
482,325,010.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,554,355.77 |
| Taxes Payable |
39,699,495.77 |
| Interest Payable |
238,837.44 |
| Dividend Payable |
-- |
| Other payables |
10,506,598.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,062,341.81 |
| Other Current Liabilities |
193,452,751.31 |
| Sub-Total of Current Liabilities |
943,692,530.97 |
| Long-term Loans |
200,009,640.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,745,577.31 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
224,399,999.99 |
| Sub-Total of Non-Current Liabilities |
588,773,942.81 |
| Total Liabilities |
1,532,466,473.78 |
| Paid-In Capital(Or Share Stock) |
1,003,810,338.00 |
| Capital Surplus |
1,908,639,493.75 |
| Surplus Reserve |
284,447,296.79 |
| LESS:Treasury Stock |
249,983,355.83 |
| Undistributed Profits |
3,015,560,294.01 |
| Minority Stockholder's Interest |
431,351,229.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,009,993,234.25 |
| Owner's Equity（Stockholder's Equity） |
6,441,344,463.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,973,810,937.38 |
